# Real-world Safety and Effectiveness of Infliximab in Pediatric Patients With Acute Kawasaki Disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-safety-and-effectiveness-of-infliximab-in-pediatric-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Masaru Miura,Tohru Kobayashi,Toru Igarashi,Hiromichi Hamada,Naomi Iwata,Yoshifumi Sasaki,Miyuki Matsukawa,Noriko Sato,Hajime Kubo,Syuji Takei |
| Citations | 30 |
| DOI | 10.1097/inf.0000000000002503 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1097/inf.0000000000002503 |
| OpenAlex ID | https://openalex.org/W2994631339 |
| PMID | 31815838 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Miyuki Matsukawa](https://scholariq.org/researchers/miyuki-matsukawa/)

## Paper primary topic

- [Kawasaki Disease and Coronary Complications](https://scholariq.org/topics/kawasaki-disease-and-coronary-complications/)

## Paper topics

- [Kawasaki Disease and Coronary Complications](https://scholariq.org/topics/kawasaki-disease-and-coronary-complications/)
- [Lymphadenopathy Diagnosis and Analysis](https://scholariq.org/topics/lymphadenopathy-diagnosis-and-analysis/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.